MannKind | Sustainability Performance
Develops and commercializes therapeutic products for diseases such as diabetes and pulmonary conditions. Focuses on innovative drug delivery systems and improving patient care.
1991
United States
201 - 500 employees
Pharmaceuticals
$100M - 500M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4508
Overallⓘ#903
in United Statesⓘ#97
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projectionsControversy level
Powered by illuminem